6038

COM:BUCHANG

步长制药

  • Stock

Last Close

17.00

22/11 07:00

Market Cap

16.94B

Beta: -

Volume Today

7.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
655.35M
-
843.19M
28.66%
913.45M
8.33%
1.09B
18.91%
1.32B
21.76%
1.42B
7.50%
1.66B
16.48%
2.35B
41.66%
3.30B
40.67%
3.81B
15.49%
4.36B
14.38%
average payables
264.25M
-
291.97M
10.49%
365.93M
25.33%
514.11M
40.49%
669.83M
30.29%
686.05M
2.42%
887.28M
29.33%
1.54B
74.00%
2.22B
43.56%
2.45B
10.38%
2.39B
2.30%
average receivables
3.11B
-
3.21B
3.02%
3.02B
5.80%
3.22B
6.41%
3.52B
9.48%
3.37B
4.33%
2.83B
15.98%
2.89B
2.08%
2.78B
3.74%
2.34B
15.76%
2.14B
8.81%
book value per share
3.96
-
4.26
7.37%
6.92
62.51%
12.07
74.60%
11.41
5.53%
12.03
5.49%
12.22
1.59%
12.40
1.44%
13.04
5.18%
11.18
14.30%
10.50
6.03%
capex per share
-0.49
-
-0.20
59.89%
-0.46
134.67%
-0.65
39.67%
-1.26
94.51%
-1.15
9.13%
-0.59
48.28%
-0.49
18.27%
-0.39
19.18%
-0.49
25.29%
-0.48
2.44%
capex to depreciation
-6.11
-
-2.06
66.29%
-2.44
18.42%
-2.36
2.97%
-4.92
107.95%
-3.52
28.38%
-1.71
51.31%
-1.26
26.32%
-0.85
32.78%
-1.09
28.53%
-0.88
19.01%
capex to operating cash flow
-0.46
-
-0.12
74.91%
-0.23
97.03%
-0.41
79.18%
-0.74
82.57%
-0.64
13.88%
-0.25
60.45%
-0.27
8.42%
-0.33
19.88%
-0.20
39.96%
3.23
1,736.68%
capex to revenue
-0.06
-
-0.02
66.66%
-0.04
108.05%
-0.06
33.38%
-0.10
90.76%
-0.10
8.67%
-0.05
51.55%
-0.03
27.84%
-0.03
17.93%
-0.04
32.09%
-0.04
11.95%
cash per share
1.18
-
2.01
70.74%
1.76
12.69%
3.61
105.57%
1.85
48.71%
1.46
21.21%
1.99
36.09%
1.68
15.50%
1.55
7.56%
2.60
67.56%
0.95
63.54%
days of inventory on hand
191.47
-
152.03
20.60%
179.09
17.80%
209.21
16.82%
217.24
3.84%
215.23
0.93%
294.16
36.67%
269.95
8.23%
338.61
25.43%
326.76
3.50%
396.18
21.25%
days payables outstanding
65.32
-
53.42
18.22%
79.29
48.43%
104.31
31.55%
111.42
6.81%
96.99
12.95%
175.63
81.08%
189.10
7.67%
220.31
16.51%
206.82
6.12%
191.42
7.44%
days sales outstanding
149.36
-
102.53
31.36%
98.44
3.98%
97.47
0.99%
98.81
1.38%
79.75
19.29%
68.53
14.07%
70.77
3.27%
56.96
19.51%
54.36
4.57%
57.35
5.50%
debt to assets
0.13
-
0.18
44.41%
0.12
31.25%
0.00
99.74%
0.09
29,084.63%
0.11
19.87%
0.13
14.16%
0.15
17.64%
0.15
2.26%
0.14
2.65%
0.16
8.45%
debt to equity
0.21
-
0.37
76.43%
0.27
26.75%
0.00
99.83%
0.14
28,675.91%
0.16
19.65%
0.20
21.63%
0.25
26.38%
0.25
2.60%
0.26
3.95%
0.28
9.84%
dividend yield
0.02
-
0.02
22.02%
0.00
87.52%
0.00
12.86%
0.03
1,327.72%
0.05
62.18%
0.04
26.01%
0.10
143.70%
0.03
67.20%
0.02
26.37%
0.06
139.62%
earnings yield
0.02
-
0.03
13.27%
0.07
167.20%
0.03
58.15%
0.05
55.91%
0.09
83.81%
0.08
1.78%
0.07
13.78%
0.06
24.22%
-0.07
233.77%
0.02
122.93%
enterprise value
48.90B
-
48.82B
0.17%
49.36B
1.11%
55.08B
11.57%
34.59B
37.19%
22.48B
35.00%
23.89B
6.27%
27.50B
15.09%
25.65B
6.74%
24.24B
5.48%
21.53B
11.19%
enterprise value over ebitda
28.20
-
24.07
14.63%
11.61
51.76%
20.46
76.19%
14.41
29.60%
8.15
43.45%
8.22
0.86%
9.39
14.30%
10.32
9.85%
10.00
3.09%
13.05
30.49%
ev to operating cash flow
43.90
-
27.42
37.55%
23.28
15.10%
33.00
41.79%
17.63
46.58%
10.96
37.82%
9.12
16.86%
14.04
54.02%
19.42
38.34%
8.80
54.70%
-131.06
1,589.80%
ev to sales
5.69
-
4.72
17.00%
4.24
10.35%
4.47
5.55%
2.50
44.18%
1.65
34.06%
1.68
1.87%
1.72
2.50%
1.63
5.30%
1.62
0.35%
1.65
1.90%
free cash flow per share
0.58
-
1.52
161.27%
1.59
4.08%
0.95
40.15%
0.44
53.64%
0.65
47.56%
1.76
170.50%
1.29
26.77%
0.80
37.64%
2.00
149.43%
-0.63
131.38%
free cash flow yield
0.01
-
0.03
161.27%
0.03
4.08%
0.02
49.45%
0.01
13.84%
0.03
133.05%
0.09
152.01%
0.06
34.55%
0.04
31.78%
0.10
150.38%
-0.04
138.75%
graham net net
1.57
-
0.02
98.44%
-3.71
15,224.26%
0.84
122.53%
-0.26
131.19%
-1.37
426.78%
-1.98
44.31%
-3.17
60.04%
-3.67
15.66%
-2.93
20.23%
-3.76
28.36%
graham number
10.04
-
11.07
10.28%
23.07
108.38%
21.46
6.98%
19.10
10.98%
21.16
10.80%
21.90
3.49%
21.67
1.08%
18.49
14.64%
19.76
6.87%
8.26
58.23%
income quality
0.83
-
1.18
42.77%
0.60
49.15%
0.94
57.11%
1.20
26.96%
1.08
10.19%
1.34
24.19%
1.06
20.41%
1.07
0.58%
-1.60
250.05%
-0.51
67.89%
intangibles to total assets
0.08
-
0.08
7.83%
0.44
477.56%
0.37
15.64%
0.37
1.24%
0.35
3.95%
0.33
5.43%
0.32
5.09%
0.30
4.04%
0.19
36.11%
0.07
63.59%
interest coverage
46.20
-
16.61
64.04%
27.56
65.88%
12.58
54.34%
22.90
82.00%
24.78
8.19%
17.76
28.33%
16.31
8.17%
10.45
35.94%
14.27
36.55%
7.89
44.72%
interest debt per share
0.87
-
1.68
93.32%
2.03
20.43%
0.16
92.31%
1.63
944.87%
2.05
25.99%
2.56
24.70%
3.25
27.18%
3.35
2.96%
2.97
11.29%
3.06
3.03%
inventory turnover
1.91
-
2.40
25.94%
2.04
15.11%
1.74
14.40%
1.68
3.70%
1.70
0.94%
1.24
26.83%
1.35
8.97%
1.08
20.28%
1.12
3.63%
0.92
17.52%
invested capital
0.21
-
0.37
76.43%
0.27
26.75%
0.00
99.83%
0.14
28,675.91%
0.16
19.65%
0.20
21.63%
0.25
26.38%
0.25
2.60%
0.26
3.95%
0.28
9.84%
market cap
49.25B
-
49.25B
0.00%
49.25B
0.00%
58.88B
19.54%
34.96B
40.62%
21.93B
37.28%
23.01B
4.92%
25.52B
10.91%
23.33B
8.58%
23.24B
0.38%
18.81B
19.04%
net current asset value
1.86B
-
1.17B
36.80%
-2.51B
313.51%
2.46B
198.09%
1.47B
40.36%
37.93M
97.41%
-375.39M
1,089.79%
-1.09B
190.21%
-1.18B
8.62%
-685.34M
42.08%
-923.04M
34.68%
net debt to ebitda
-0.20
-
-0.21
6.13%
0.03
112.19%
-1.41
5,523.48%
-0.15
89.23%
0.20
232.90%
0.31
51.28%
0.68
121.75%
0.93
37.74%
0.41
55.64%
1.65
297.24%
net income per share
1.13
-
1.28
13.27%
3.42
167.20%
1.69
50.44%
1.42
16.11%
1.65
16.38%
1.74
5.43%
1.68
3.54%
1.17
30.72%
-1.55
233.26%
0.29
118.57%
operating cash flow per share
1.08
-
1.72
59.85%
2.05
19.10%
1.60
22.05%
1.70
6.54%
1.80
5.52%
2.35
30.77%
1.77
24.62%
1.19
32.59%
2.49
108.67%
-0.15
105.96%
payables turnover
5.59
-
6.83
22.28%
4.60
32.63%
3.50
23.98%
3.28
6.38%
3.76
14.87%
2.08
44.78%
1.93
7.12%
1.66
14.17%
1.76
6.52%
1.91
8.04%
receivables turnover
2.44
-
3.56
45.68%
3.71
4.15%
3.74
1.00%
3.69
1.36%
4.58
23.91%
5.33
16.38%
5.16
3.17%
6.41
24.24%
6.71
4.79%
6.36
5.21%
research and ddevelopement to revenue
0.02
-
0.02
16.60%
0.02
6.38%
0.03
34.85%
0.04
9.38%
0.04
0.43%
0.04
0.87%
0.03
6.00%
0.03
22.21%
0.02
26.69%
0.02
28.52%
return on tangible assets
0.18
-
0.16
14.26%
0.40
154.47%
0.15
62.39%
0.13
10.60%
0.15
8.05%
0.14
5.39%
0.12
13.67%
0.08
35.11%
-0.10
225.85%
0.02
116.92%
revenue per share
8.31
-
9.99
20.28%
11.27
12.79%
11.80
4.71%
12.03
1.96%
11.97
0.50%
12.78
6.73%
14.47
13.27%
14.25
1.53%
13.52
5.15%
11.78
12.85%
roe
0.29
-
0.30
5.49%
0.49
64.42%
0.14
71.62%
0.12
11.20%
0.14
10.32%
0.14
3.78%
0.14
4.91%
0.09
34.13%
-0.14
255.49%
0.03
119.76%
roic
0.24
-
0.21
11.25%
0.37
73.14%
0.13
64.62%
0.10
25.22%
0.12
22.15%
0.12
0.48%
0.11
10.91%
0.07
34.86%
0.15
119.32%
0.03
83.06%
sales general and administrative to revenue
0.01
-
0.01
2.41%
0.02
34.65%
0.02
28.28%
0.02
23.14%
0.02
16.85%
0.02
37.15%
0.02
25.72%
0.02
8.74%
0.02
1.92%
shareholders equity per share
3.96
-
4.26
7.37%
6.92
62.51%
12.07
74.60%
11.41
5.53%
12.03
5.49%
12.22
1.59%
12.40
1.44%
13.04
5.18%
11.18
14.30%
10.50
6.03%
stock based compensation to revenue
tangible asset value
3.71B
-
3.76B
1.23%
327.93M
91.27%
5.79B
1,664.64%
6.19B
6.89%
6.81B
10.13%
6.74B
1.09%
6.58B
2.31%
7.18B
9.09%
8.02B
11.75%
10.22B
27.30%
tangible book value per share
3.59
-
3.63
1.23%
0.32
91.27%
5.54
1,648.04%
5.37
3.14%
5.97
11.17%
6.04
1.20%
5.95
1.46%
6.49
9.09%
7.26
11.75%
9.24
27.30%
working capital
1.89B
-
1.26B
33.21%
-975.87M
177.41%
2.76B
383.02%
1.88B
31.93%
1.28B
31.82%
895.26M
30.16%
172.57M
80.72%
1.19B
589.59%
2.03B
70.60%
1.42B
29.81%

All numbers in (except ratios and percentages)